Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    ES07 - Impact of Tumor Plasticity and Molecular/Immune Adaptations in Treatment Sensitivity and Resistance

    • 12:00 - 13:00
    • 8/07/2022
    • Location: Strauss 1/2
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Tumor Biology and Biomarkers
    • +

      Session Moderator

      12:50 - 13:00  |  Presenter: Benjamin Besse

      • Abstract

      Loading...

    • +

      Session Moderator

      12:50 - 13:00  |  Presenter: Yuko Minami

      • Abstract

      Loading...

    • +

      ES07.01 - Session Introduction

      12:00 - 12:01  |  Presenter: Benjamin Besse

      • Abstract

      Loading...

    • +

      ES07.02 - Session Introduction

      12:01 - 12:02  |  Presenter: Yuko Minami

      • Abstract

      Loading...

    • +

      ES07.03 - NSCLC Persister Cells and Their Role in Treatment Resistance and Disease Progression

      12:02 - 12:14  |  Presenter: Trever Bivona

      • Abstract

      Loading...

    • +

      ES07.04 - Biological Role and Actionability of Molecular/Immune Alterations after Acquired Resistance to Single-Agent and Combination Therapies (Focus on EMT, Includes SCLC)

      12:14 - 12:26  |  Presenter: Sandra Ortiz-Cuaran

      • Abstract

      Loading...

    • +

      ES07.05 - Tumor Cell Plasticity and Histological/Molecular Changes: Focus On Transition from NSCLC to SCLC

      12:26 - 12:38  |  Presenter: Triparna Sen

      • Abstract

      Loading...

    • +

      ES07.06 - Biological Advances in SCLC: Molecular Subtypes, Anti-tumor Immune Responses and Impact on Therapeutics

      12:38 - 12:50  |  Presenter: Helmut Popper

      • Abstract

      Loading...

    • +

      ES07.07 - Live Q&A

      12:50 - 13:00

      • Abstract

      Loading...

  • +

    EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
    • +

      EP08.01-090 - Association of Gender and Outcomes in Patients With Advanced NSCLC Treated With Immunotherapy Alone or in Combination With Chemotherapy Upfront.

      Presenter: Teresa Gorria

      • Abstract

      Loading...

    • +

      EP08.01-091 - Association of dNLR Score with Outcomes in Patients with Advanced NSCLC Under Immunotherapy Alone +/- Chemotherapy Upfront

      Presenter: Teresa Gorria

      • Abstract

      Loading...

  • +

    EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      EP08.02-016 - Frontline and Post-Osimertinib Therapy for EGFR-mutant Advanced NSCLC: Treatment Patterns, Outcomes, Healthcare Use and Costs

      Presenter: Benjamin Besse

      • Abstract

      Loading...

    • +

      EP08.02-041 - NVL-520, a Highly Selective ROS1 Inhibitor, in Patients with Advanced ROS1-Positive Solid Tumors: The Phase 1/2 ARROS-1 Study

      Presenter: Alexander Drilon

      • Abstract

      Loading...

    • +

      EP08.02-173 - Treatment Patterns and Outcomes Among Patients With EGFR-mutant Advanced NSCLC in the Frontline and Post-Osimertinib Settings

      Presenter: Joshua Sabari

      • Abstract

      Loading...

  • +

    P1.16 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments

    • 17:00 - 19:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      P1.16-02 - Clinical Utility of ctDNA in Advanced NSCLC at Diagnosis or Where Insufficient Tissue Was Available, Based on the ESMO ESCAT Scale

      Presenter: Laura Mezquita

      • Abstract

      Loading...

  • +

    PL03 - Plenary 3: Presidential Symposium - Top Rated Abstracts (Live Streamed Session)

    • 08:30 - 10:20
    • 8/08/2022
    • Location: Hall C1
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N/A
    • +

      PL03.10 - Discussant

      Presenter: Benjamin Besse

      • Abstract

      Loading...

  • +

    OA07 - Is There Still a Role for Chemotherapy Alone in the Management of NSCLC?

    • 11:00 - 12:00
    • 8/08/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Palliative Chemotherapy
    • +

      OA07.06 - Second Line Treatment Outcomes After Progression on Immunotherapy Plus Chemotherapy (IO-CT) In Advanced Non-small Cell Lung Cancer (aNSCLC)

      11:32 - 11:42  |  Presenter: Edouard Auclin

      • Abstract

      Loading...

  • +

    MA07 - Overcoming Resistance to EGFR Inhibitors

    • 12:15 - 13:15
    • 8/08/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      MA07.07 - Clinical/Molecular Profile of Patients with Non-small Cell Lung Cancer (NSCLC) with Incidental Pathogenic Germline Variants Detected in cfDNA

      12:42 - 12:47  |  Presenter: Laura Mezquita

      • Abstract

      Loading...

  • +

    MA10 - Updates in Thymoma

    • 14:45 - 15:45
    • 8/08/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies
    • +

      MA10.08 - Activated Pathways of Myastenia Gravis in Thymic Epithelial (TETs)

      15:17 - 15:22  |  Presenter: Jose Carlos Benítez

      • Abstract

      Loading...

  • +

    OA13 - Evolving Epidemiology of Lung Cancer Beyond Tobacco

    • 10:45 - 11:45
    • 8/09/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Oral
    • Track: Epidemiology
    • +

      OA13.04 - Prevalence of Molecular Alterations in NSCLC and Estimated Indoor Radon in Europe: RADON EUROPE Study

      10:57 - 11:07  |  Presenter: Miguel Garcia Pardo

      • Abstract

      Loading...

  • +

    OA15 - Patient Selection in Advanced NSCLC Immunotherapy

    • 14:30 - 15:30
    • 8/09/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
    • +

      OA15.05 - HUDSON: An Open-Label, Multi-Drug, Biomarker-Directed Phase 2 Study in NSCLC Patients Who Progressed on Anti-PD-(L)1 Therapy

      14:52 - 15:02  |  Presenter: Benjamin Besse

      • Abstract

      Loading...